CCSD Code 0002C: Neurofilament Light Chain billing guide

Key Takeaways

CCSD Code 0002C is the UK private healthcare diagnostic code for Neurofilament Light Chain (NfL) testing, added to the CCSD schedule in June 2021.

0002C is a diagnostic code, not a procedure code – never load it into your procedure code table or bill it as a procedure.

Fees for CCSD Code 0002C are set by individual insurers, not CCSD itself – always check each insurer’s current published fee schedule before billing.

Pabau’s claims management software supports CCSD diagnostic code submission workflows for UK private clinics.

Most billing errors on CCSD Code 0002C come from a single misunderstanding: treating it like a procedure code. Neurofilament Light Chain testing is a biomarker test, not a clinical procedure – and the way you classify it in your billing system determines whether the claim pays or bounces. For clinics now moving to private practice and coming across CCSD diagnostic codes for the first time, this distinction matters from day one.

This guide covers the definition, clinical context, documentation requirements, and insurer guidance for CCSD Code 0002C. We wrote this guide for private clinic billing staff, practice admin, and healthcare finance teams working within the UK private sector.

CCSD Code 0002C: Definition and clinical description

CCSD Code 0002C describes the Neurofilament Light Chain (NfL) diagnostic test. NfL is a structural protein released from damaged neurons into the bloodstream and cerebrospinal fluid. Elevated levels signal active neuronal injury, and clinicians use NfL in assessing neurodegenerative conditions including multiple sclerosis, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and frontotemporal dementia.

The code sits within the CCSD Diagnostic Schedule, maintained by the Clinical Coding and Schedule Development Group. CCSD added it to the UK private reimbursement schedule in June 2021, alongside related codes including 0015B (Anti Hyaluronidase Antibodies), 7263C (CSF Microscopy), and 8243C (CSF Microscopy and Culture).

Code classification: diagnostic, not procedural

This distinction is a common source of claim rejections. Per the CCSD FAQs, diagnostic codes do not constitute procedures — never load them into procedure code tables. 0002C belongs in the diagnostic charge section of your billing submission, separate from any related consultation or procedural codes.

• Code type: Diagnostic
• Schedule: CCSD Diagnostic Schedule
• Clinical category: Neurological biomarkers
• Specimen type: Blood serum or cerebrospinal fluid (CSF)
• Added to schedule: June 2021

Clinical context for CCSD Code 0002C billing

Understanding when NfL testing is clinically needed helps billing staff assess whether a claim is likely to pass insurer review. For private clinics exploring the benefits of private healthcare provision in neurology and diagnostics, NfL is an increasingly requested biomarker.

NfL levels rise when axons sustain damage, no matter the underlying cause. Neurologists use serial NfL measurements to monitor disease progression and treatment response – especially in MS patients receiving disease-modifying therapies. A single elevated reading rarely triggers payment on its own; insurers normally require clinical context and a documented clinical question.

Conditions associated with NfL testing

• Multiple sclerosis (MS) – monitoring disease activity and treatment response
• Amyotrophic lateral sclerosis (ALS) / motor neurone disease
• Alzheimer’s disease and other dementias
• Frontotemporal dementia
• Traumatic brain injury assessment
• Suspected neuroinflammatory conditions

The CCSD Technical Guide (October 2025) provides the broader framework for how diagnostic codes are structured and when they apply within a billing submission. Billing teams new to neurological biomarker claims should review chapter 35 (Diagnostic Schedule).

Documentation requirements for CCSD Code 0002C

Private insurers assess diagnostic claims against the records submitted. Weak or incomplete records are the main reason insurers query 0002C claims after initial filing. Meeting compliance requirements for UK private clinics means ensuring every element below is captured before the claim is filed.

Core documentation checklist

• Clinical reason: A clear, documented reason for requesting NfL testing – linked to a suspected or confirmed neurological diagnosis
• Requesting clinician: Name and GMC number of the specialist who ordered the test
• Specimen type and collection date: Blood serum or CSF, with the date of collection recorded
• Laboratory report: The actual NfL result with reference range, issued by the testing laboratory
• Insurer approval reference: Pre-approval number where required (check insurer-specific requirements before filing)
• Patient policy details: Membership number, insurer name, and policy type confirmed at registration

Using digital forms for clinical documentation reduces the risk of incomplete records at billing time. When you capture consent, clinical history, and test request forms electronically at the point of care, the data you need for claim filing is already structured and easy to find.

Pre-authorisation: the key variable by insurer

Pre-approval requirements for diagnostic codes vary widely across UK private insurers. Some require prior approval for neurological biomarker testing; others process the claim after the fact. Billing staff should never assume pre-approval is not needed – verify with each insurer before ordering the test.

Manage CCSD diagnostic claims without the manual overhead

Pabau gives private UK clinics a single platform for clinical documentation, digital consent forms, and claims management. See how it connects your diagnostic records to billing submissions.

Book a demo

Insurer billing guidance for CCSD Code 0002C

CCSD does not set fees for Code 0002C. As Bupa’s code search portal confirms, CCSD publishes the codes; each insurer sets its own payment rate separately. This means the same NfL test may attract different fees depending on the patient’s insurer – and trying to charge a standard rate across all payers will cause mismatches.

Bupa uses CCSD codes as its industry standard for clinical activity coding across all approved providers. For admin teams who need a single reference, the Bupa CCSD codes guide on the Pabau website covers the full schedule with practical billing context.

Insurer-specific notes

CCSD fixes none of these rates. Billing teams working across multiple insurer panels should maintain a live log of each insurer’s current 0002C rate, updated whenever insurers publish revised schedules. The features that streamline private practice billing – including built-in insurer code management – make this much more manageable at scale.

Related CCSD diagnostic codes

CCSD Code 0002C rarely appears in isolation on a neurology billing submission. Understanding the codes most commonly submitted alongside it reduces the risk of incorrect ordering and billing disputes. Private clinics investing in robust private GP clinic software benefit from having all related diagnostic codes mapped in one place.

Codes commonly submitted with 0002C

• 7263C – CSF Microscopy: Used when cerebrospinal fluid is collected and examined as part of a neurological workup. May accompany NfL testing when CSF (rather than blood) is the specimen source
• 8243C – CSF Microscopy and Culture: An extended version of CSF analysis that includes culture for infectious cause. Used when infection is part of the differential diagnosis
• 0015B – Anti Hyaluronidase Antibodies (AHYA): Added to the diagnostic schedule at the same time as 0002C (June 2021). CCSD added it to the diagnostic schedule at the same time as 0002C (June 2021) — not clinically related to NfL but part of the same schedule update

When 0002C and 7263C appear on the same claim, insurers may check whether the lab genuinely ran both from the same CSF sample or whether two separate specimen collections took place. Documenting the specimen type, collection date, and clinical rationale for each code prevents this from triggering a query. For teams managing UK data protection requirements alongside clinical records, keeping accurate, time-stamped records of specimen collection is both a clinical and a legal requirement.

Common billing errors with CCSD Code 0002C

The following errors appear regularly in CCSD diagnostic code claims across UK private clinics. Clear pre-filing checks prevent most of them. For practices building out their billing workflows, the claims management software approach replaces manual checklists with system-enforced validation.

• Loading 0002C into the procedure code table: This causes the code to submit under the wrong schedule section, triggering immediate rejection. Diagnostic codes live in the diagnostic charge section only
• Submitting without pre-approval: Some insurers require prior approval for neurological biomarker testing. Submitting without it results in a non-payment decision, not a query – the insurer simply declines the claim
• Missing laboratory report: Submitting a code without the matching lab result attached (or available on request) exposes the claim to audit challenge. The lab report is the evidence that the test occurred
• Incorrect specimen documentation: Failing to specify whether NfL was measured from serum or CSF when CSF analysis codes are also on the claim
• No clinical indication in the notes: An NfL result without documented clinical context (the question being answered) is unlikely to pass a medical review query

Teams new to neurological biomarker billing often benefit from reviewing their private practice management processes as a whole before tackling individual code errors. Regular gaps in records workflows tend to produce the same billing errors across multiple codes.

Conclusion

CCSD Code 0002C is a straightforward diagnostic code once the code type is understood. The most common mistakes – loading it as a procedure, skipping pre-authorisation, or submitting without a lab report – the right documentation checks in place prevent all of them.

Pabau’s claims management software connects clinical documentation directly to billing submissions, reducing the manual checking that causes most CCSD diagnostic code errors. To see how it works for UK private clinics handling neurological biomarker billing, book a demo.

Continue your research

Need a full reference for Bupa CCSD codes? Bupa CCSD codes guide covers the complete schedule with practical billing guidance for UK private providers.

Looking to reduce claim rejections across your practice? Features that streamline private practice billing outlines the workflow tools that reduce manual claim errors.

Managing compliance for a UK private clinic? UK data protection checklist covers the documentation and data governance requirements that run alongside clinical billing requirements.

Frequently Asked Questions